Abstract | OBJECTIVE: METHOD: Seventy-five seasonal allergic rhinitis patients were randomly divided into two groups. Patients in Group 1 received intranasal beclomethasone dipropionate for two weeks and patients in Group 2 had rhinophototherapy added to the same medical therapy as Group 1. The effectiveness of treatments was evaluated with the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Nasal Obstruction Symptom Evaluation scale (NOSE) questionnaires and active anterior rhinomanometry. RESULTS:
After treatment, significant improvement was observed in Group 2 vs Group 1 in terms of RQLQ (p = 0.011) and NOSE (p = 0.001) scores. In Group 2, significant differences were observed between before and after treatment for inspiratory total nasal resistance (p = 0.004). However, no significant differences vs. baseline were observed in Group 1. CONCLUSION:
|
Authors | Elif Karali, Akif Gunes, Ahmet Ural, Isa Akin, Emine Ozsari, Oya Kalaycioglu |
Journal | Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
(Acta Otorhinolaryngol Ital)
Vol. 41
Issue 2
Pg. 151-158
(Apr 2021)
ISSN: 1827-675X [Electronic] Italy |
PMID | 34028460
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2021 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy. |
Chemical References |
|
Topics |
- Beclomethasone
- Double-Blind Method
- Humans
- Nasal Obstruction
(drug therapy, etiology)
- Quality of Life
- Rhinitis, Allergic, Seasonal
(complications, drug therapy)
- Rhinomanometry
|